Keith Rickert

2.9k total citations
40 papers, 1.8k citations indexed

About

Keith Rickert is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Keith Rickert has authored 40 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 14 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Oncology. Recurrent topics in Keith Rickert's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (7 papers) and HER2/EGFR in Cancer Research (6 papers). Keith Rickert is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (7 papers) and HER2/EGFR in Cancer Research (6 papers). Keith Rickert collaborates with scholars based in United States, Germany and United Kingdom. Keith Rickert's co-authors include Judith P. Klinman, Michael J. Knapp, Barbara Imperiali, Katie B. Shannon, Masaki Unno, Kathleen Coll, Kenneth A. Thomas, S.M. Soisson, George D. Hartman and Jennifer M. Shipman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Keith Rickert

40 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Rickert United States 23 1.0k 475 218 187 182 40 1.8k
Mark L. McLaughlin United States 25 978 1.0× 792 1.7× 221 1.0× 165 0.9× 172 0.9× 99 2.3k
Demetri T. Moustakas United States 23 1.3k 1.3× 509 1.1× 115 0.5× 131 0.7× 163 0.9× 28 2.0k
D. Bruce Fulton United States 29 1.6k 1.5× 251 0.5× 230 1.1× 107 0.6× 99 0.5× 64 2.7k
Bernard Gsell Switzerland 17 907 0.9× 302 0.6× 200 0.9× 133 0.7× 372 2.0× 19 1.7k
Ricardo J. Solá Puerto Rico 15 1.1k 1.1× 344 0.7× 95 0.4× 342 1.8× 483 2.7× 15 1.9k
David Hangauer United States 27 1.3k 1.2× 524 1.1× 353 1.6× 98 0.5× 167 0.9× 64 2.0k
Yoshitomo Hamuro United States 27 1.5k 1.4× 473 1.0× 113 0.5× 189 1.0× 80 0.4× 48 2.5k
Howard Einspahr United States 21 1.1k 1.1× 308 0.6× 122 0.6× 91 0.5× 122 0.7× 58 2.0k
Franz‐Josef Meyer‐Almes Germany 26 1.7k 1.6× 725 1.5× 502 2.3× 144 0.8× 81 0.4× 88 2.6k
Robert C. Woodworth United States 32 1.4k 1.4× 354 0.7× 512 2.3× 159 0.9× 175 1.0× 92 3.0k

Countries citing papers authored by Keith Rickert

Since Specialization
Citations

This map shows the geographic impact of Keith Rickert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Rickert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Rickert more than expected).

Fields of papers citing papers by Keith Rickert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Rickert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Rickert. The network helps show where Keith Rickert may publish in the future.

Co-authorship network of co-authors of Keith Rickert

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Rickert. A scholar is included among the top collaborators of Keith Rickert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Rickert. Keith Rickert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hutchinson, Mark R., Jeffrey A. Ruffolo, Michael J. Iannotti, et al.. (2024). Toward enhancement of antibody thermostability and affinity by computational design in the absence of antigen. mAbs. 16(1). 2362775–2362775. 10 indexed citations
3.
Amant, André H. St., Keith Rickert, Vaheh Oganesyan, et al.. (2019). A Diene‐Containing Noncanonical Amino Acid Enables Dual Functionality in Proteins: Rapid Diels–Alder Reaction with Maleimide or Proximity‐Based Dimerization. Angewandte Chemie International Edition. 58(25). 8489–8493. 28 indexed citations
4.
Amant, André H. St., Feng‐Ying Huang, Keith Rickert, et al.. (2019). A Diene‐Containing Noncanonical Amino Acid Enables Dual Functionality in Proteins: Rapid Diels–Alder Reaction with Maleimide or Proximity‐Based Dimerization. Angewandte Chemie. 131(25). 8577–8581. 2 indexed citations
5.
Li, Qing, Norman Peterson, Richard N. Hanna, et al.. (2019). Antibody Fragment F(ab′)2 Targeting Caveolae-Associated Protein PV1 for Selective Kidney Targeting and Retention. Molecular Pharmaceutics. 17(2). 507–516. 9 indexed citations
6.
Burwell, Timothy, Norman Peterson, Jennifer Cann, et al.. (2019). Targeted drug delivery via caveolae-associated protein PV1 improves lung fibrosis. Communications Biology. 2(1). 92–92. 23 indexed citations
7.
Shan, Lu, Qun Du, Lena Shirinian, et al.. (2019). Experimentally guided computational antibody affinity maturation with de novo docking, modelling and rational design. PLoS Computational Biology. 15(5). e1006980–e1006980. 43 indexed citations
8.
Chen, Feng, Kai Ma, Brian Madajewski, et al.. (2018). Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer. Nature Communications. 9(1). 4141–4141. 142 indexed citations
9.
Li, Qing, Jason B. White, Norman Peterson, et al.. (2018). Tumor uptake of pegylated diabodies: Balancing systemic clearance and vascular transport. Journal of Controlled Release. 279. 126–135. 19 indexed citations
10.
Rickert, Keith, et al.. (2016). Combining phage display with de novo protein sequencing for reverse engineering of monoclonal antibodies. mAbs. 8(3). 501–512. 16 indexed citations
11.
Clayton, Gina M., Daniel J. Klein, Keith Rickert, et al.. (2013). Structure of the Bacterial Deacetylase LpxC Bound to the Nucleotide Reaction Product Reveals Mechanisms of Oxyanion Stabilization and Proton Transfer. Journal of Biological Chemistry. 288(47). 34073–34080. 44 indexed citations
12.
Dudkin, Vadim, Cheng Wang, Kenneth L. Arrington, et al.. (2012). Pyridyl aminothiazoles as potent Chk1 inhibitors: Optimization of cellular activity. Bioorganic & Medicinal Chemistry Letters. 22(7). 2613–2619. 6 indexed citations
13.
Soisson, S.M., Sangita B. Patel, Pravien Abeywickrema, et al.. (2010). Structural definition and substrate specificity of the S28 protease family: the crystal structure of human prolylcarboxypeptidase. BMC Structural Biology. 10(1). 16–16. 38 indexed citations
14.
Foster, Kelley A., Andrew Danziger, Nancy Kwon, et al.. (2008). Attenuation of edema and infarct volume following focal cerebral ischemia by early but not delayed administration of a novel small molecule KDR kinase inhibitor. Neuroscience Research. 63(1). 10–16. 11 indexed citations
15.
Rickert, Keith, Noel Byrne, Ronald E. Diehl, et al.. (2008). Structure of Human Prostasin, a Target for the Regulation of Hypertension. Journal of Biological Chemistry. 283(50). 34864–34872. 30 indexed citations
16.
Rickert, Keith, Michael D. Schaber, Maricel Torrent, et al.. (2007). Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSP. Archives of Biochemistry and Biophysics. 469(2). 220–231. 40 indexed citations
17.
Torrent, Maricel, Keith Rickert, Bo‐Sheng Pan, & Laura Sepp‐Lorenzino. (2004). Analysis of the activating mutations within the activation loop of leukemia targets Flt-3 and c-Kit based on protein homology modeling. Journal of Molecular Graphics and Modelling. 23(2). 153–165. 10 indexed citations
18.
Bilodeau, Mark T., Georgia B. McGaughey, Kathleen Coll, et al.. (2004). The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase. Bioorganic & Medicinal Chemistry Letters. 14(11). 2941–2945. 27 indexed citations
19.
Manley, Peter J., Mark T. Bilodeau, Kathleen Coll, et al.. (2003). 2,4-Disubstituted pyrimidines: A novel class of KDR kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(10). 1673–1677. 23 indexed citations
20.
Rickert, Keith, Jonathan E. Sears, Warren F. Beck, & Gary W. Brudvig. (1991). Mechanism of irreversible inhibition of oxygen evolution in photosystem II by tris(hydroxymethyl)aminomethane. Biochemistry. 30(32). 7888–7894. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026